Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,796 | 746 | 98.2% |
| Education | $176.97 | 4 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54.08 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,041 | 72 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $966.30 | 130 | $0 (2022) |
| EMD Serono, Inc. | $686.50 | 34 | $0 (2024) |
| PFIZER INC. | $640.61 | 32 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $536.32 | 26 | $0 (2024) |
| SK Life Science, Inc. | $493.99 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $479.84 | 25 | $0 (2024) |
| Eisai Inc. | $441.88 | 22 | $0 (2024) |
| Kyowa Kirin, Inc. | $355.55 | 18 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $341.08 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,561 | 111 | ABBVIE INC. ($332.86) |
| 2023 | $2,432 | 112 | AbbVie Inc. ($291.15) |
| 2022 | $2,174 | 108 | Biohaven Pharmaceutical Holding Company Ltd. ($165.79) |
| 2021 | $1,951 | 114 | Teva Pharmaceuticals USA, Inc. ($265.59) |
| 2020 | $1,112 | 95 | Supernus Pharmaceuticals, Inc. ($412.49) |
| 2019 | $1,112 | 75 | Supernus Pharmaceuticals, Inc. ($139.13) |
| 2018 | $864.57 | 81 | Supernus Pharmaceuticals, Inc. ($251.64) |
| 2017 | $821.18 | 57 | Supernus Pharmaceuticals, Inc. ($131.46) |
All Payment Transactions
753 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Immunology | ||||||
| 12/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.58 | General |
| 11/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: Neurology | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.24 | General |
| 11/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: EPILEPSY | ||||||
| 11/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/13/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Central Nervous System | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/25/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Neuropsychiatry | ||||||
| 10/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: PAIN | ||||||
| 10/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Neurology | ||||||
| 10/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.87 | General |
| 10/07/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.60 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 558 | 717 | $240,604 | $60,523 |
| 2022 | 9 | 580 | 754 | $242,635 | $60,227 |
| 2021 | 10 | 636 | 806 | $252,256 | $67,494 |
| 2020 | 12 | 716 | 885 | $284,556 | $66,367 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 283 | $88,862 | $23,758 | 26.7% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 51 | 63 | $47,376 | $11,623 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $39,196 | $9,773 | 24.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 52 | 83 | $19,736 | $4,927 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 50 | $10,800 | $2,802 | 25.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 23 | 26 | $9,004 | $2,060 | 22.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 24 | 48 | $7,003 | $1,654 | 23.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 14 | 14 | $7,166 | $1,502 | 21.0% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 21 | 23 | $6,467 | $1,314 | 20.3% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 24 | 31 | $4,770 | $993.87 | 20.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 14 | $224.00 | $117.60 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 224 | 321 | $100,794 | $25,758 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 108 | 108 | $51,624 | $11,290 | 21.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 54 | 87 | $24,012 | $6,274 | 26.1% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 24 | 24 | $17,188 | $5,028 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 86 | $18,576 | $4,811 | 25.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 23 | 23 | $9,568 | $2,124 | 22.2% |
| 76882 | Limited ultrasound scan of joint or other extremity structure lacking blood vessels | Office | 2022 | 30 | 46 | $7,452 | $1,801 | 24.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 22 | 41 | $7,175 | $1,678 | 23.4% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 18 | 18 | $6,246 | $1,463 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 231 | 326 | $102,740 | $27,984 | 27.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 89 | 89 | $42,662 | $10,578 | 24.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 61 | 84 | $22,934 | $6,250 | 27.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 101 | $21,816 | $6,046 | 27.7% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 15 | 15 | $13,145 | $3,269 | 24.9% |
About Dr. Jonas Vanags, M.D
Dr. Jonas Vanags, M.D is a Neurology healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1245474048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonas Vanags, M.D has received a total of $13,027 in payments from pharmaceutical and medical device companies, with $2,561 received in 2024. These payments were reported across 753 transactions from 76 companies. The most common payment nature is "Food and Beverage" ($12,796).
As a Medicare-enrolled provider, Vanags has provided services to 2,490 Medicare beneficiaries, totaling 3,162 services with total Medicare billing of $254,611. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Savannah, GA
- Active Since 04/23/2009
- Last Updated 09/25/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245474048
Products in Payments
- TROKENDI XR (Drug) $891.38
- NURTEC ODT (Drug) $731.89
- UBRELVY (Drug) $448.52
- Fycompa (Drug) $382.66
- BOTOX (Biological) $342.98
- KESIMPTA (Drug) $336.22
- VALTOCO (Drug) $332.73
- INGREZZA (Drug) $273.50
- NUPLAZID (Drug) $259.25
- Aimovig (Biological) $256.89
- Hizentra (Biological) $237.61
- Trudhesa (Drug) $236.14
- EPIDIOLEX (Drug) $217.74
- QULIPTA (Drug) $212.87
- VYEPTI (Biological) $206.19
- NUEDEXTA (Drug) $206.18
- NOURIANZ (Drug) $192.52
- RADICAVA (Drug) $175.80
- Briviact (Drug) $168.09
- Nourianz (Drug) $163.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Savannah
Victor Rosenfeld, M.d, M.D
Neurology — Payments: $413,963
Robert Macgregor, M.d, M.D
Neurology — Payments: $51,325
Dr. Brandi Fleenor, Md, MD
Neurology — Payments: $45,288
Dr. Joel Greenberg, M.d, M.D
Neurology — Payments: $38,325
Stephen Donahue, Md, MD
Neurology — Payments: $26,870
Dr. James Sutton, M.d, M.D
Neurology — Payments: $18,745